Levetiracetam Amarox

Levetiracetam, the active ingredient in Levetiracetam Amarox, is an anticonvulsant presented as a tablet for oral use. It treats various seizure types in patients with epilepsy.

GNH USA supplies Levetiracetam Amarox as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is used to manage seizure disorders across several epilepsy syndromes.

Partial seizures: reduces seizure frequency and severity in focal epilepsy. Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. Myoclonic seizures: diminishes rapid muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or imbalance. - Fatigue: feeling unusually tired or lacking energy. - Headache: mild to moderate cranial pain. - Irritability: increased mood swings or agitation. - Nausea: upset stomach or urge to vomit. - Somnolence: excessive sleepiness.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Mood changes: including depression, anxiety, or suicidal thoughts. - Hematologic abnormalities: like leukopenia or thrombocytopenia. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Allergic reactions: anaphylaxis or angioedema. - Multiorgan involvement: rare cases of systemic hypersensitivity.

When prescribing Levetiracetam, clinicians should consider several safety measures.

Dose adjustment: evaluate renal function and adjust dose in impairment. Pregnancy: use only if benefits outweigh potential risks, as data are limited. Breastfeeding: assess infant exposure, as drug is excreted in milk. Psychiatric monitoring: watch for mood alterations or behavioral changes. Drug interactions: review concomitant medications for potential effects. Store at ambient temperature: keep below 25°C in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam exposure. - Phenytoin: may lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Fluconazole: may increase levetiracetam levels. - Rifampin: may reduce levetiracetam concentrations. - Alcohol: can enhance central nervous system depression. - Other antiepileptics: monitor for additive side effects.